Post-inflammatory Pigmentary Alteration (PIPA)-Like Disorder Following COVID-19 Vaccination

Larry M. Bush • Priscila M. Fiallo • Maria T. Vazquez-Pertejo, DOI: 10.7759/cureus.87222  Abstract SARS-CoV-2 (COVID-19) infection has been associated with various cutaneous manifestations presenting concomitantly with and following clinical resolution of active infection. Similarly,…[...]

Read More

A Case of Graves’ Disease Exacerbation Triggered by BNT162b2 Vaccination

Hideyuki Iwamoto • Tomohiko Kimura • Erina Nakao • et. al., DOI: 10.7759/cureus.84863 Abstract Graves' disease is an autoimmune thyroid disorder characterized by the production of thyroid-stimulating hormone receptor antibodies and is one of the leading causes…[...]

Read More

Behavioral and Health Outcomes of mRNA COVID-19 Vaccination: A Case-Control Study in Japanese Small and Medium-Sized Enterprises

Eiji Nakatani • Hisayo Morioka • Takayuki Kikuchi • Masanori Fukushima, DOI: 10.7759/cureus.75652  Abstract Background Despite ongoing waves of Coronavirus disease 2019 (COVID-19) infections, including significant surges such as the 10th wave, understanding the impact of messenger…[...]

Read More